Hem › Multipel skleros › Arizona
Kliniska studier för Multipel skleros i Arizona
6 studier för Multipel skleros söker deltagare vid platser i Arizona.
Städer i Arizona
Officiell studietext (engelska)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Perseverance Research Center,LLC, Scottsdale
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Clinical Endpoints, LLC, Scottsdale
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Gilbert
- TG Therapeutics Investigational Trial Site, Phoenix
- TG Therapeutics Investigational Trial Site, Scottsdale
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Arizona, Tucson
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195, Phoenix
- Perseverance Research Center- Site Number : 8400138, Scottsdale
RekryterarFas 3
Ålder 18 till 60 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Ctr for Neurology and Spine, Phoenix
- AZ Integrated Neuro and Spine, Phoenix
- Center for Neurosciences, Tucson
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT07225504Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.